Structural basis for accommodation of emerging B.1.351 and B.1.1.7 variants by two potent SARS-CoV-2 neutralizing antibodies.

Structure
Gabriele CeruttiLawrence Shapiro

Abstract

Emerging SARS-CoV-2 strains, B.1.1.7 and B.1.351, from the UK and South Africa, respectively, show decreased neutralization by monoclonal antibodies and convalescent or vaccinee sera raised against the original wild-type virus, and are thus of clinical concern. However, the neutralization potency of two antibodies, 1-57 and 2-7, which target the receptor-binding domain (RBD) of the spike, was unaffected by these emerging strains. Here, we report cryo-EM structures of 1-57 and 2-7 in complex with spike, revealing each of these antibodies to utilize a distinct mechanism to bypass or accommodate RBD mutations. Notably, each antibody represented an immune response with recognition distinct from those of frequent antibody classes. Moreover, many epitope residues recognized by 1-57 and 2-7 were outside hotspots of evolutionary pressure for ACE2 binding and neutralizing antibody escape. We suggest the therapeutic use of antibodies, such as 1-57 and 2-7, which target less prevalent epitopes, could ameliorate issues of monoclonal antibody escape.

References

Dec 4, 2003·Journal of Synchrotron Radiation·Paul D AdamsThomas C Terwilliger
Jun 25, 2004·Nucleic Acids Research·Ian W DavisDavid C Richardson
Jul 21, 2004·Journal of Computational Chemistry·Eric F PettersenThomas E Ferrin
Dec 2, 2004·Acta Crystallographica. Section D, Biological Crystallography·Paul Emsley, Kevin Cowtan
May 14, 2005·Journal of Structural Biology·Christian SulowayBridget Carragher
Aug 31, 2006·Bioinformatics·Barry J GrantLeo S D Caves
Aug 8, 2007·Journal of Molecular Biology·Evgeny Krissinel, Kim Henrick
May 15, 2013·Nucleic Acids Research·Jian YeJames M Ostell
Aug 19, 2015·Nature Methods·Benjamin A BaradJames S Fraser
May 1, 2016·Nucleic Acids Research·James DunbarCharlotte M Deane
Feb 7, 2017·Nature Methods·Ali PunjaniMarcus A Brubaker
Jun 7, 2018·Acta Crystallographica. Section D, Structural Biology·Tristan Ian Croll
Jan 10, 2017·Global Challenges·Stefan Elbe, Gemma Buckland-Merrett
Feb 23, 2020·Science·Daniel WrappJason S McLellan
Feb 23, 2020·The Lancet Infectious Diseases·Ensheng DongLauren Gardner
Mar 24, 2020·Nature·Ewen CallawayJeff Tollefson
Jun 20, 2020·Nature·Davide F RobbianiMichel C Nussenzweig
Jul 15, 2020·Science·Meng YuanIan A Wilson
Aug 18, 2020·Bioinformatics·Matthew I J RaybouldCharlotte M Deane
Sep 4, 2020·Protein Science : a Publication of the Protein Society·Eric F PettersenThomas E Ferrin
Oct 13, 2020·Nature·Christopher O BarnesPamela J Bjorkman
Nov 12, 2020·The New England Journal of Medicine·Bina ChoiJonathan Z Li
Dec 17, 2020·The New England Journal of Medicine·Ralph S Baric
Jan 22, 2021·Nature Communications·Zhiqiang KuZhiqiang An
Jan 31, 2021·Lancet·Ester C SabinoNuno R Faria
Mar 9, 2021·Nature·Pengfei WangDavid D Ho
Mar 16, 2021·The Journal of Biological Chemistry·Rafael Bayarri-OlmosMikkel-Ole Skjoedt
Apr 23, 2021·Cell Host & Microbe·Pengfei WangDavid D Ho

❮ Previous
Next ❯

Software Mentioned

EMringer
Resolve - EM
Fit
GraphPad Prism
SAbPred
- Map
UCSF Chimera
Molprobity
hclust
Coot

Related Concepts

Related Feeds